Xponance’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Sell |
4,338
-46
| -1% | -$6.98K | 0.01% | 850 |
|
|
2025
Q1 | $660K | Sell |
4,384
-2,634
| -38% | -$396K | 0.01% | 846 |
|
|
2024
Q4 | $1.3M | Sell |
7,018
-251
| -3% | -$46.3K | 0.01% | 637 |
|
|
2024
Q3 | $1.43M | Buy |
7,269
+226
| +3% | +$44.5K | 0.01% | 609 |
|
|
2024
Q2 | $1.45M | Sell |
7,043
-130
| -2% | -$26.9K | 0.01% | 575 |
|
|
2024
Q1 | $1.94M | Buy |
7,173
+428
| +6% | +$116K | 0.02% | 525 |
|
|
2023
Q4 | $1.59M | Sell |
6,745
-644
| -9% | -$152K | 0.02% | 535 |
|
|
2023
Q3 | $1.45M | Buy |
7,389
+335
| +5% | +$65.7K | 0.02% | 545 |
|
|
2023
Q2 | $1.48M | Sell |
7,054
-4,811
| -41% | -$1.01M | 0.02% | 543 |
|
|
2023
Q1 | $2.39M | Buy |
11,865
+42
| +0.4% | +$8.48K | 0.04% | 415 |
|
|
2022
Q4 | $2.58M | Buy |
11,823
+1,027
| +10% | +$224K | 0.04% | 388 |
|
|
2022
Q3 | $2.13M | Buy |
10,796
+1,021
| +10% | +$201K | 0.04% | 375 |
|
|
2022
Q2 | $2.09M | Buy |
9,775
+1,516
| +18% | +$324K | 0.04% | 360 |
|
|
2022
Q1 | $2.35M | Buy |
8,259
+105
| +1% | +$29.8K | 0.04% | 338 |
|
|
2021
Q4 | $3.07M | Buy |
8,154
+811
| +11% | +$306K | 0.05% | 289 |
|
|
2021
Q3 | $3.03M | Sell |
7,343
-184
| -2% | -$75.9K | 0.06% | 263 |
|
|
2021
Q2 | $2.78M | Sell |
7,527
-2,229
| -23% | -$824K | 0.05% | 289 |
|
|
2021
Q1 | $2.83M | Buy |
9,756
+52
| +0.5% | +$15.1K | 0.06% | 256 |
|
|
2020
Q4 | $2.43M | Buy |
9,704
+13
| +0.1% | +$3.25K | 0.05% | 281 |
|
|
2020
Q3 | $2.2M | Buy |
9,691
+764
| +9% | +$173K | 0.05% | 271 |
|
|
2020
Q2 | $1.56M | Buy |
+8,927
| New | +$1.56M | 0.04% | 300 |
|